|
시장보고서
상품코드
2083430
모기 기피제 시장 : 형태별, 원재료별, 도포 방법별, 사용 환경별, 유통 채널별 - 세계 시장 예측(2026-2032년)Mosquito Repellent Market by Form, Raw Material, Application Method, Usage Environment, Distribution Channel - Global Forecast 2026-2032 |
||||||
360iResearch
모기 기피제 시장은 2032년까지 연평균 복합 성장률(CAGR) 6.16%로 성장해 125억 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도(2025년) | 82억 2,000만 달러 |
| 추정 연도(2026년) | 87억 1,000만 달러 |
| 예측 연도(2032년) | 125억 달러 |
| CAGR(%) | 6.16% |
모기 기피제 시장은 소비자의 건강, 야외 레저 활동, 여행, 그리고 매개성 질환 예방이라는 분야가 교차하는 지점에 위치해 있습니다. 이러한 수요는 CDC(미국 질병통제예방센터) 및 미국 환경보호청(EPA)이 제시한 공중보건 지침에 힘입어 증가하고 있습니다. 이 지침에서는 라벨의 지침에 따라 사용할 경우, DEET, 피카리딘, IR3535, 레몬 유칼립투스 오일/PMD, 2-운데카논 등 EPA에 등록된 유효 성분의 사용을 권장하고 있습니다.
기후 변화, 도시화, 국제 여행, 그리고 매개체 매개 질환에 대한 소비자의 인식 제고로 인해 이 시장의 양상은 재편되고 있습니다. 공중보건 당국은 살충제 처리된 모기장, 방충망, 위생 관리, 지역사회 차원의 모기 방제와 더불어 모기 기피제를 실용적인 개인 보호 수단 중 하나로 간주하는 경향이 강해지고 있습니다.
인공지능(AI)은 매개체 모니터링, 예측 분석, 제제 스크리닝, 수요 계획을 통해 모기 기피제의 밸류체인에 영향을 미치기 시작했습니다. AI를 활용한 모델은 기상 데이터, 위성 데이터, 유인 트랩 데이터, 질병 보고 데이터를 통합하여 모기의 발생 압력을 파악하고, 제조업체가 계절적 요인 및 감염병 유행에 따른 수요 패턴에 맞추어 재고를 조정할 수 있도록 지원합니다.
아시아태평양은 높은 인구 밀도, 열대·아열대 기후, 그리고 남아시아 및 동남아시아 전역에서 반복적으로 발생하는 뎅기열과 말라리아의 위험으로 인해 여전히 중요한 수요 중심지입니다. WHO는 서태평양 지역 및 동남아시아 지역을 뎅기열의 주요 유행 지역으로 지목하고 있으며, 인도, 인도네시아, 태국, 필리핀 등 각국의 공중보건 당국은 계절적 감염 기간 동안 모기에 물리지 않도록 예방 조치를 취할 것을 계속해서 강조하고 있습니다.
아세안 시장은 뎅기열의 풍토병 위험, 열대 기후, 인구 밀집 도시 지역, 그리고 모기향, 기화기, 스프레이, 에어로졸, 로션, 패치, 외용 모기 기피제의 과다 사용과 같은 요인의 영향을 받고 있습니다. 동남아시아 전역에서 진행되는 공중보건 계몽 활동에서는 모기 서식지 제거와 모기 물림 예방이 일관되게 강조되고 있으며, 도시 및 도시 주변 지역에서는 가정용 해충 방제 제품과 개인용 모기 기피제가 중요한 역할을 하고 있습니다.
미국에서는 EPA(미국 환경보호청)에 등록된 모기 퇴치 제품, 야외 레크리에이션, 웨스트나일 바이러스 예방 지침, 그리고 CDC(미국 질병통제예방센터)가 지지하는 유효 성분에 관한 권고 사항이 주도적인 역할을 하고 있습니다. 한편, 캐나다에서는 계절별 사용, 라벨 표기에 따른 효능 표기, 그리고 따뜻한 계절의 보호 기능이 중시되고 있습니다. 멕시코와 브라질에서는 뎅기열, 지카열, 치쿤구니아열에 대한 인식이 더욱 높아지고 있으며, 특히 이집트얼룩모기(Aedes aegypti)가 반복적으로 공중보건상의 우려를 야기하고 있는 도시 지역이나 열대 지역에서 가정용 모기 퇴치 및 개인용 방충 제품에 대한 수요가 증가하고 있습니다.
업계의 선도 기업들은 효능에 대한 투명성, 유효 성분에 대한 명확한 정보 제공, 그리고 공인된 규제 기준에 부합하는 효능 표기를 우선시해야 합니다. 자외선 차단 지속 시간, 연령별 사용 지침, 도포 빈도, 재도포의 필요성, 자외선 차단제와의 병용에 대해 설명하는 브랜드는 소비자의 신뢰를 높이고 오용을 줄일 수 있습니다.
본 요약본은 공중보건 기관, 규제 당국, 과학 문헌, 제품 라벨, 소매 현장 관찰 및 업계 정보원을 바탕으로 한 2차 조사에 근거하고 있습니다. 주요 참고 자료로는 WHO의 질병 감시 데이터, CDC의 예방 지침, 미국 EPA의 살충제 등록 정보, 각 지역의 살생물제 관련 규정, 그리고 국가 및 지역 보건 당국의 공식 권고 사항이 포함됩니다.
모기 기피제 시장은 계절 한정으로 편의성을 중시하는 카테고리에서 예방 의료 및 가정의 안전을 지키는 핵심 요소로 진화하고 있습니다. 입증된 질병 부담, 기후에 따라 달라지는 모기의 활동, 침입종의 확산, 그리고 안전하고 효과적인 성분에 대한 소비자의 관심 증대가 이 부문의 견조한 성장세를 지속적으로 뒷받침하고 있습니다.
The Mosquito Repellent Market is projected to grow by USD 12.50 billion at a CAGR of 6.16% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 8.22 billion |
| Estimated Year [2026] | USD 8.71 billion |
| Forecast Year [2032] | USD 12.50 billion |
| CAGR (%) | 6.16% |
The mosquito repellent market sits at the intersection of consumer health, outdoor recreation, travel, and vector-borne disease prevention. Demand is reinforced by public health guidance from the CDC and U.S. EPA, which recommend EPA-registered active ingredients such as DEET, picaridin, IR3535, oil of lemon eucalyptus/PMD, and 2-undecanone when used according to label directions.
Market relevance is also supported by the persistent global burden of mosquito-borne disease. The WHO reported an estimated 249 million malaria cases and 608,000 malaria deaths in 2022, while dengue transmission has expanded across tropical and subtropical regions, increasing the relevance of topical repellents, spatial repellents, treated textiles, coils, vaporizers, and household insect control products.
The landscape is being reshaped by climate variability, urbanization, international travel, and growing consumer awareness of vector-borne diseases. Public health authorities increasingly position mosquito repellents as a practical layer of personal protection alongside insecticide-treated nets, screens, sanitation, and community mosquito control.
Product strategy is shifting from basic insect avoidance to evidence-based protection, better skin feel, longer duration, family-friendly labeling, and reduced odor. At the same time, retail is moving toward omnichannel buying, with consumers comparing efficacy claims, active ingredients, dermatology positioning, sustainability credentials, and regulatory approvals before purchase.
Artificial intelligence is beginning to influence the mosquito repellent value chain through vector surveillance, predictive analytics, formulation screening, and demand planning. AI-supported models can combine weather, satellite, trap, and disease-reporting data to identify mosquito pressure and help manufacturers align inventory with seasonal and outbreak-driven demand patterns.
In product development, machine learning can support faster screening of ingredient combinations, controlled-release systems, fragrance masking, and packaging optimization. However, AI does not replace toxicology, field testing, label compliance, or regulatory review; it strengthens decision-making when paired with validated laboratory and real-world performance data.
Asia-Pacific remains a critical demand center because of dense populations, tropical and subtropical climates, and recurring dengue and malaria risk across South and Southeast Asia. WHO has identified the Western Pacific and South-East Asia regions as important dengue-affected areas, while national public health agencies in countries such as India, Indonesia, Thailand, and the Philippines continue to emphasize mosquito-bite prevention during seasonal transmission periods.
North America is shaped by outdoor recreation, West Nile virus awareness, tick-and-mosquito prevention routines, and strong trust in EPA-registered products, particularly in the United States and Canada. Latin America faces sustained dengue pressure, especially in urban areas where Aedes mosquitoes thrive in standing water, and countries across the region have reported recurring dengue, chikungunya, and Zika concerns under Pan American Health Organization surveillance.
Europe is seeing higher attention to invasive mosquito species, including Aedes albopictus, and travel-related disease prevention as warmer seasons and cross-border mobility increase exposure concerns. The Middle East combines expatriate mobility, tourism, irrigation-linked mosquito habitats, and hot-weather outdoor exposure. Africa retains the strongest public health relevance, with WHO data showing the region bears the largest share of malaria cases and deaths, supporting demand for mosquito repellents alongside insecticide-treated nets, indoor residual spraying, environmental management, and broader vector control programs.
ASEAN markets are influenced by endemic dengue risk, tropical climates, dense urban settlements, and high use of coils, vaporizers, sprays, aerosols, lotions, patches, and topical mosquito repellents. Public health messaging across Southeast Asia consistently reinforces source reduction and bite prevention, making household insect control and personal repellent formats important in both urban and peri-urban settings.
The GCC emphasizes premium personal care, travel retail, hospitality, and outdoor evening protection, supported by hot climates, high mobility, and expatriate populations. The European Union prioritizes biocidal product compliance, safety documentation, substantiated efficacy claims, and clear labeling under established regulatory frameworks, making compliance capability a key differentiator for mosquito repellent suppliers.
BRICS countries combine large populations, varied disease exposure, expanding modern retail, and fast-growing e-commerce adoption, creating diverse needs across household, topical, and institutional repellent applications. G7 markets favor clinically credible, regulated, convenient formats, including picaridin, DEET, IR3535, and plant-derived active ingredient options where permitted by regulators. NATO countries show additional demand through military, humanitarian, peacekeeping, and field-deployment use cases where reliable mosquito protection supports operational readiness and personnel health in mosquito-prone environments.
The United States leads with EPA-registered mosquito repellents, outdoor recreation, West Nile virus prevention guidance, and CDC-backed recommendations for active ingredients, while Canada emphasizes seasonal use, label-compliant claims, and protection during warmer months. Mexico and Brazil are more strongly linked to dengue, Zika, and chikungunya awareness, increasing demand for household mosquito control and personal protection, particularly in urban and tropical regions where Aedes aegypti is a recurring public health concern.
In Europe, the United Kingdom, Germany, France, Italy, and Spain balance travel health, summer outdoor use, camping, gardening, and EU biocidal rules, with added attention to invasive mosquito monitoring and prevention advice. Russia faces more seasonal and region-specific demand influenced by climate variation and outdoor activity patterns. China and India represent high-relevance opportunities due to population scale, urbanization, monsoon-linked mosquito activity, and exposure to mosquito-borne diseases in several regions, supporting demand across coils, vaporizers, aerosols, creams, lotions, and plug-in formats.
Japan and South Korea prioritize convenience, quality, low-odor formats, urban household protection, and compact products suited to modern retail and e-commerce channels. Australia combines outdoor lifestyles with mosquito-borne disease prevention in tropical, coastal, and wetland-adjacent areas, where public health authorities routinely advise bite avoidance, protective clothing, screens, and approved repellents during periods of elevated mosquito activity.
Industry leaders should prioritize efficacy transparency, clear active-ingredient education, and claims that align with recognized regulatory standards. Brands that explain duration of protection, age-use guidance, application frequency, reapplication needs, and compatibility with sunscreen can improve consumer trust and reduce misuse.
Manufacturers should diversify across topical, spatial, fabric-treatment, and household formats while investing in long-lasting, low-odor, skin-friendly formulations. Partnerships with retailers, travel health providers, public health campaigns, and e-commerce platforms can strengthen seasonal activation, while AI-enabled demand planning can reduce stockouts during outbreak-driven demand spikes.
Leaders should also localize assortments by climate, disease exposure, consumer format preference, and regulatory status of active ingredients. Evidence-based labeling, post-market safety monitoring, sustainable packaging, and responsible communication around natural or plant-based claims can help improve credibility in both mature and emerging mosquito repellent markets.
This executive summary is grounded in secondary research from public health agencies, regulatory bodies, scientific literature, product labels, retail observations, and trade sources. Key references include WHO disease surveillance, CDC prevention guidance, U.S. EPA repellent registration information, regional biocidal product frameworks, and public advisories from national and regional health authorities.
Insights are synthesized through market segmentation by active ingredient, product format, distribution channel, end user, and geography. Findings are validated through triangulation of disease burden, regulatory acceptance, consumer behavior, vector ecology, climate sensitivity, and commercial availability to ensure practical and data-backed market interpretation without relying on market sizing, share, or forecasting.
The mosquito repellent market is evolving from a seasonal convenience category into a core component of preventive health and household protection. Verified disease burden, climate-sensitive mosquito activity, invasive mosquito expansion, and rising consumer attention to safe, effective ingredients continue to support category resilience.
Future winners will combine regulatory credibility, proven efficacy, convenient formats, and localized go-to-market execution. Organizations that invest in evidence-based innovation, AI-supported planning, responsible claims, and transparent consumer education are best positioned to compete across mature, emerging, and outbreak-sensitive markets.